Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 2023.
Article Versions
- You are currently viewing a Latest version of this article (March 1, 2023 - 04:00).
- latest version (April 1, 2023 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2023 The Journal of Rheumatology
Author Information
- Sofia Exarchou,
- Johan K. Wallman,
- Daniela Di Giuseppe,
- Eva Klingberg,
- Valgerdur Sigurdardottir,
- Sara Wedrén,
- Ulf Lindström,
- Carl Turesson,
- Lennart T. H. Jacobsson and
- Johan Askling
- SE, Exarchou, MD, PhD, Department of Clinical Sciences Malmö, Rheumatology, Lund University, Malmö, Sweden
- JKW, Wallman, MD, PhD, Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden and Department of Rheumatology, Skåne University Hospital, Lund, Sweden
- DDiG, Di Giuseppe, PhD, Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden
- EK, Klingberg, MD, PhD, Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden and Department of Rheumatology, Sahlgrenska University Hospital, Gothenburg, Sweden
- VS, Sigurdardottir, MD, Center for Clinical Research (CKF) Dalarna, Uppsala University, Falun, Sweden and Department of Rheumatology, Falun Hospital, Falun, Sweden
- SW, Wedrén, MD, PhD, Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden and Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden
- UL, Lindström, MD, PhD, Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- CT, Turesson, Prof., Department of Clinical Sciences Malmö, Rheumatology, Lund University, Malmö, Sweden and Department of Rheumatology, Skåne University Hospital, Malmö, Sweden
- LTHJ, Jacobsson, Prof., Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- JA, Askling, Prof., Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
-
Funding: This study was supported by AbbVie (4-1624/2020), Amgen (4-2584/2019), Eli Lilly (4- 691/2020), Novartis (4-2568/2019) and Pfizer (4-3321/2019). The sponsors were allowed to comment on the study protocol and were provided with a report of the results, but had no influence on the study design, data collection, data analysis, data interpretation, writing of the report or decision to submit the manuscript. This study was further supported by unrestricted grants from the Swedish Rheumatism Association (R-837511), the Swedish Psoriasis Foundation (Decision date 20190823), the Gösta A Karlsson 60-year Foundation (Decision date 20190824) and Skåne University Hospital (Decision date 20180627).
Conflict of interest: SE: Consultant of AbbVie, Amgen, Janssen-Cilag, Novartis, UCB Pharma; JKW: Consultant of AbbVie, Amgen, Celgene, Eli Lilly, Novartis; DDiG: None declared; EK: Grant/research support from Roche, Consultant of Novartis, Speakers bureau Eli Lilly; VS: Consultant of Novartis, Sanofi, AstraZeneca; SW: None declared; UL: None declared; CT: Grant/research support from Bristol-Myers Squibb, Consultant of Roche, Speakers bureau AbbVie, Bristol-Myers Squibb, Nordic Drugs, Pfizer and Roche; LTHJ: Consultant of AbbVie, Eli Lilly, Janssen, Novartis and Pfizer; JA: Grant/research support: JA acts or has acted as PI for agreements between Karolinska Institutet and the following entities, mainly in the context of the ARTIS national safety monitoring programme of immunomodulators in rheumatology: AbbVie, BMS, Eli Lilly, Merck, Pfizer, Roche, Samsung Bioepis, Sanofi, and UCB Pharma.
Ethics approval and consent to participate: Ethical approval for the study was granted by the Regional Ethics Committee in Stockholm, Sweden (Dnr. 2015/1844-31/2). Consent from individual patients was not required by the approval.
- Corresponding author: Name: Sofia Exarchou Address: Department of Clinical Sciences Malmö, Rheumatology, Lund University, Jan Waldenströms gata 1B, 205 02, Malmö, Sweden. E-mail: sofiaexar@hotmail.com.